周周
Lv21
130 积分
2024-01-18 加入
-
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
2小时前
待确认
-
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2小时前
已完结
-
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
3个月前
已完结
-
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
4个月前
已完结
-
Central control of fever and female body temperature by RANKL/RANK
8个月前
已完结
-
Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group
8个月前
已完结
-
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
8个月前
已完结
-
Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide
1年前
已完结
-
T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor
1年前
已完结
-
Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML
1年前
已完结